Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huadong Medicine is a leading Chinese pharmaceutical company headquartered in Hangzhou, specializing in the research, development, manufacturing, and distribution of a broad range of healthcare products. The company operates across the entire pharmaceutical industry chain, with core therapeutic focuses in oncology, endocrinology, autoimmune diseases, and nephrology. Huadong has established a significant presence in the global medical aesthetics market through its subsidiary Sinclair Pharma and maintains an extensive commercial network covering thousands of hospitals in China. In recent years, the company has aggressively transitioned toward innovation, building a robust pipeline of antibody-drug conjugates (ADCs), cell therapies, and metabolic treatments through both internal R&D and strategic international partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on East China Pharmaceuticals.